$148.24+31.49% · 3M
Moving avg
1W+5.05%
1M+10.59%
3M+31.49%
6M+15.00%
YTD+7.46%
1Y+26.36%
3Y+17.05%
5Y-6.27%
52-week range
$108.3577% of range$160.27
Company health
Value0/6
Growth3/6
Profitability5/6
Health5/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (2084%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$41.87B
Enterprise value
$40.68B
P/E ratio (TTM)
27.77x
P/S ratio (TTM)
5.41x
EV/EBITDA
20.74x
Per share & returns
EPS (TTM)
$5.00
Dividend yield
0.73%
Beta (1Y)
1.25
30-day change
+10.59%
Trading
Volume (24h)
1.00M
Previous close
$149.49
Shares outstanding
282.43M
About Agilent Technologies, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
A
Agilent Technologies, Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker A.
Frequently asked questions
What is Agilent Technologies, Inc.'s market cap?
Agilent Technologies, Inc. (A) has a market capitalization of $41.87B.
What is Agilent Technologies, Inc.'s P/E ratio?
Agilent Technologies, Inc. trades at a price-to-earnings (P/E) ratio of 27.77.
What exchange does A trade on?
A trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 363.20-0.63%
$356.16B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.88-0.26%
$290.07B cap
AstraZeneca PLCLON: AZN
£116.66-0.31%
$244.33B cap